Medical comorbidity in bipolar disorder: Reprioritizing unmet needs

Current Opinion in Psychiatry

Volumn 20, Issue 4, 2007, Pages 406-416

  McIntyre, Roger S ^a,b,c   Soczynska, Joanna K ^b,c   Beyer, John L ^d   Woldeyohannes, Hanna O ^c   Law, Candy W Y ^c   Miranda, Andrew ^c   Konarski, Jakub Z ^b,c   Kennedy, Sidney H ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Cardiovascular disease; Diabetes; Diabetes mellitus; Medical comorbidity; Obesity

Indexed keywords

AGE DISTRIBUTION; ALZHEIMER DISEASE; ARTHRITIS; ASTHMA; BIPOLAR DISORDER; BODY MASS; CARDIOVASCULAR DISEASE; COMORBIDITY; CONFIDENCE INTERVAL; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; HEALTH CARE SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; KIDNEY DISEASE; LUNG DISEASE; MEDLINE; METABOLIC SYNDROME X; MIGRAINE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; OBESITY; PANCREATITIS; PARKINSON DISEASE; PROSTATE HYPERTROPHY; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SEX RATIO; STROKE; THYROID DISEASE;

BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; DIABETES MELLITUS; HEALTH SERVICES NEEDS AND DEMAND; HEALTH STATUS; HUMANS; OBESITY; RESPIRATORY TRACT DISEASES; THYROID DISEASES;

EID: 34250024344     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/YCO.0b013e3281938102     Document Type: Review

References (105)

1. Akiskal HS, Bourgeois ML, Angst J, et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 59 (Suppl 1):S5-S30.
2. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73 (1-2):123-131.
3. Fenn HH, Bauer MS, Alshuler L, et al. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span. J Affect Disord 2005; 86:47-60.
4. Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58:844-850.
5. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005; 67:1-8.
6. Black DW, Winokur G, Bell S, et al. Complicated mania. Comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry 1988; 45:232-236.
7. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005; 293:2528-2530.
8. Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006; 68:684-691.
9. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58:175-189.
10. Morriss R, Mohammed FA. Metabolism, lifestyle and bipolar affective disorder. J Psychopharmacol 2005; 19 (6 Suppl):94-101.
11. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004; 6:368-373.
12. McIntyre RS, Konarski JZ, Soczynska JK, et al. Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv 2006; 57:1140-1144.
13. Calabrese JR, Hirschfeld RM, Reed M, et al. Impact of bipolar disorder on a US community sample. J Clin Psychiatry 2003; 64:425-432.
14. Oedegaard KJ, Fasmer OB. Is migraine in unipolar depressed patients a bipolar spectrum trait? J Affect Disord 2005; 84 (2-3):233-242.
15. Hirschfeld RM, Calabrese JR, Weissman MM, et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64:53-59.
16. Thompson WK, Kupfer DJ, Fagiolini A, et al. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry 2006; 67:783-788.
17. Beyer J, Kuchibhatla M, Gersing K, Krishnan KR. Medical comorbidity in a bipolar outpatient clinical population. Neuropsychopharmacology 2005; 30:401-404.
18. Sajatovic M, Blow FC, Ignacio RV. Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry 2006; 21:582-587.
19. Fagiolini A, Frank E, Scott JA, et al. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7:424-430.
20. Ruzickova M, Slaney C, Garnham J, Alda M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 2003; 48:458-461.
21. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999; 156:1417-1420.
22. Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002; 70:19-26.
23. Fasmer OB. The prevalence of migraine in patients with bipolar and unipolar affective disorders. Cephalalgia 2001; 21:894-899.
24. Mahmood T, Romans S, Silverstone T. Prevalence of migraine in bipolar disorder. J Affect Disord 1999; 52 (1-3):239-241.
25. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache 2003; 43:940-949.
26. McIntyre RS, Konarski JZ, Wilkins K, et al. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache 2006; 46:973-982.
27. Nakimuli-Mpungu E, Musisi S, Mpungu SK, Katabira E. Primary mania versus HIV-related secondary mania in Uganda. Am J Psychiatry 2006; 163:1349-1354.
28. Johannessen L, Strudsholm U, Foldager L, Munk-Jorgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord 2007; 7:77-81.
29. Snowdon J. A retrospective case-note study of bipolar disorder in old age. Br J Psychiatry 1991; 158:485-490.
30. Shulman KI, Tohen M, Satlin A, et al. Mania compared with unipolar depression in old age. Am J Psychiatry 1992; 149:341-345.
31. Wylie ME, Mulsant BH, Pollock BG, et al. Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry 1999; 7:77-83.
32. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002; 63:207-213.
33. Elmslie JL, Silverstone JT, Mann JI, et al. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000; 61:179-184.
34. Fagiolini A, Frank E, Houck PR, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002; 63:528-533.
35. Simon GE, Von Korff M, Saunders K, et al. Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry 2006; 63:824-830.
36. Basile VS, Masellis M, McIntyre RS, et al. Genetic dissection of atypical antipsychotic-induced weight gain: novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 2001; 62 (Suppl 23):45-66.
37. Wang PW, Sachs GS, Zarate CA, et al. Overweight and obesity in bipolar disorders. J Psychiatr Res 2006; 40:762-764.
38. McIntyre RS, Konarski JZ, Wilkins K, et al. Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well being. Can J Psychiatry 2006; 51:274-280. A thorough and comprehensive review of key aspects of medical comorbidities salient to the bipolar population.
39. Strudsholm U, Johannessen L, Foldager L, Munk-Jorgensen P. Increased risk for pulmonary embolism in patients with bipolar disorder. Bipolar Disord 2005; 7:77-81.
40. Valle J, Ayuso-Gutierrez JL, Abril A, Ayuso-Mateos JL. Evaluation of thyroid function in lithium-naive bipolar patients. Eur Psychiatry 1999; 14:341-345.
41. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55:580-592.
42. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150:1115-1121.
43. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002; 68(2-3):167-181.
44. Kilbourne AM, Cornelius JR, Han X, et al. General-medical conditions in older patients with serious mental illness. Am J Geriatr Psychiatry 2005; 13:250-254.
45. Lin HC, Tsai SY, Lee HC. Increased risk of developing stroke among patients with bipolar disorder after an acute mood episode: a six-year follow-up study. J Affect Disord 2006; [Epub ahead of print].
46. Zanetti MV, Cordeiro Q, Busatto GF. Late onset bipolar disorder associated with white matter hyperintensities: a pathophysiological hypothesis. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:551-556.
47. Robinson RG. Poststroke depression: prevalence, diagnosis, treatment, and disease progression. Biol Psychiatry 2003; 54:376-387.
48. Rybakowski JK, Wykretowicz A, Heymann-Szlachcinska A, Wysocki H. Impairment of endothelial function in unipolar and bipolar depression. Biol Psychiatry 2006; 60:889-891.
49. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286:1195-1200.
50. Coodin S. Body mass index in persons with schizophrenia. Can J Psychiatry 2001; 46:549-555.
51. McElroy S, Allison D, Bray G. Obesity and mental disorders. New York: Taylor & Francis; 2006. A thorough and comprehensive review of key aspects of medical comorbidities salient to the bipolar population.
52. Elmslie JL, Mann JI, Silverstone JT, et al. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001; 62:486-491.
53. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003; 160:112-117.
54. Fagiolini A, Kupfer DJ, Rucci P, et al. Suicide attempts and ideation in patients with bipolar I disorder. J Clin Psychiatry 2004; 65:509-514.
55. McIntyre RS, Konarski JZ, Misener VL, Kennedy SH. Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry 2005; 17:83-93.
56. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
57. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005; 28:2289-2304.
58. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112:2735-2752.
59. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143-3421.
60. McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80:19-32.
61. Taylor V, Macqueen G. Associations between bipolar disorder and metabolic syndrome: a review. J Clin Psychiatry 2006; 67:1034-1041. A thorough and comprehensive review of key aspects of medical comorbidities salient to the bipolar population.
62. Basu R, Brar JS, Chengappa KN, et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype. Bipolar Disord 2004; 6:314-318.
63. Van Winkel R, De Hert A, Van Eyck D, et al. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Biol Psychiatry 2006; [Epub ahead of print].
64. McIntyre RS, Mancini DA, McCann S, et al. Valproate, bipolar disorder and polycystic ovarian syndrome. Bipolar Disord 2003; 5:28-35.
65. O'Donovan C, Kusumakar V, Graves GR, Bird DC. Menstrual abnormalities and polycystic ovary syndrome in women taking valproate for bipolar mood disorder. J Clin Psychiatry 2002; 63:322-330.
66. Joffe H, Cohen LS, Suppes T, et al. Longitudinal follow-up of reproductive and metabolic features of valproate-associated polycystic ovarian syndrome features: a preliminary report. Biol Psychiatry 2006; 60:1378-1381.
67. Rasgon NL, Altshuler LL, Fairbanks L, et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005; 7:246-259.
68. Gildea EF, McLean VL, Man EB. Oral and intravenous dextrose tolerance curves of patients with manic-depressive psychosis. Arch Neurol Psychiat 1943; 49:852-859.
69. Van der Velde CD, Gordon MW. Manic-depressive illness, diabetes mellitus, and lithium carbonate. Arch Gen Psychiatry 1969; 21:478-485.
70. Lilliker SL. Prevalence of diabetes in a manic-depressive population. Compr Psychiatry 1980; 21:270-275.
71. Lustman PJ, Griffith LS, Clouse RE, Cryer PE. Psychiatric illness in diabetes mellitus. Relationship to symptoms and glucose control. J Nerv Ment Dis 1986; 174:736-742.
72. Newcomer JW, Craft S, Fucetola R, et al. Glucose-induced increase in memory performance in patients with schizophrenia. Schizophr Bull 1999; 25:321-335.
73. Kessing LV, Nilsson FM, Siersma V, Andersen PK. Increased risk of developing diabetes in depressive and bipolar disorders? J Psychiatr Res 2004; 38:395-402.
74. Kreyenbuhl J, Dickerson FB, Medoff DR, et al. Extent and management of cardiovascular risk factors in patients with type 2 diabetes and serious mental illness. J Nerv Ment Dis 2006; 194:404-410.
75. Breslau N, Merikangas K, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994; 44 (10 Suppl 7):S17-S22.
76. Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990; 47:849-853.
77. Minden SL. Mood disorders in multiple sclerosis: diagnosis and treatment. J Neurovirol 2000; 6 (Suppl 2):S160-S167.
78. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004; 10:575-581.
79. Harden CL, Goldstein MA. Mood disorders in patients with epilepsy: epidemiology and management. CNS Drugs 2002; 16:291-302.
80. Post RM, Weiss SR. Convergences in course of illness and treatments of the epilepsies and recurrent affective disorders. Clin EEG Neurosci 2004; 35:14-24.
81. Cole DP, Thase ME, Mallinger AG, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry 2002; 159:116-121.
82. Cassidy F, Ahearn EP, Carroll BJ. Thyroid function in mixed and pure manic episodes. Bipolar Disord 2002; 4:393-397.
83. McIntyre RS, Mancini DA, Parikh S, Kennedy SH. Lithium revisited. Can J Psychiatry 2001; 46:322-327.
84. Ramschak-Schwarzer S, Radkohl W, Stiegler C, et al. Interaction between psychotropic drugs and thyroid hormone metabolism - an overview. Acta Med Austriaca 2000; 27:8-10.
85. Gitlin M. Lithium and the kidney: an updated review. Drug Saf 1999; 20:231-243.
86. Redelmeier DA, Tan SH, Booth GL. The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med 1998; 338:1516-1520.
87. Judd LL, Akiskal HS. Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder. Curr Psychiatry Rep 2003; 5:417-418.
88. Evans DL, Charney DS. Mood disorders and medical illness: a major public health problem. Biol Psychiatry 2003; 54:177-180.
89. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci 2005; 8:555-560.
90. McIntyre RS, McElroy S, Konarski JZ, et al. Substance use disorders and overweight/obesity in bipolar I disorder: Preliminary evidence for competing addictions. J Clin Psychiatry (in press).
91. Leverich GS, McElroy SL, Suppes T, et al. Early physical and sexual abuse associated with an adverse course of bipolar illness. Biol Psychiatry 2002; 51:288-297.
92. Leverich GS, Altshuler LL, Frye MA, et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry 2003; 64:506-515.
93. Dong M, Giles WH, Felitti VJ, et al. Insights into causal pathways for ischemic heart disease: adverse childhood experiences study. Circulation 2004; 110:1761-1766.
94. McIntyre RS. Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. J Clin Psychiatry 2002; 63 (Suppl 3):15-20.
95. McIntyre RS, McCann SM, Kennedy SH. Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities. Can J Psychiatry 2001; 46:273-281.
96. Collino M, Aragno M, Mastrocola R, et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 2006; 530 (1-2):70-80.
97. McIntyre RS, Konarski JZ. Tolerability profiles of atypical antipsychotics. J Clin Psychiatry 2005; 66 (Suppl 3):28-36.
98. Khanzode SD, Dakhale GN, Khanzode SS, et al. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003; 8:365-370.
99. Rush AJ, Giles DE, Schlesser MA, et al. The dexamethasone suppression test in patients with mood disorders. J Clin Psychiatry 1996; 57:470-484.
100. Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001; 55:651-659.
101. Plotsky PM, Owens MJ, Nemeroff CB. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. Psychiatr Clin North Am 1998; 21:293-307.
102. McEwen BS. Mood disorders and allostatic load. Biol Psychiatry 2003; 54:200-207.
103. Bowden CL, Calabrese JR, Wallin BA, et al. Illness characteristics of patients in clinical drug studies of mania. Psychopharmacol Bull 1995; 31:103-109.
104. Suppes T, Dennehy EB, Hirschfeld RM, et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 2005; 66:870-886.
105. Yatham LN, Kennedy SH, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord 2005; 7 (Suppl 3):5-69.